These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6906368)

  • 1. Review of excipients and pH's for parenteral products used in the United States.
    Wang YC; Kowal RR
    J Parenter Drug Assoc; 1980; 34(6):452-62. PubMed ID: 6906368
    [No Abstract]   [Full Text] [Related]  

  • 2. Standards for particulate matter in all parenteral drug products.
    Jeffrey LP; Pinkus TF
    Am J Hosp Pharm; 1976 Sep; 33(9):879-80. PubMed ID: 984053
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to the applicability of proposed large volume parenteral regulations to small volume parenteral drug products.
    Bull Parenter Drug Assoc; 1976; 30(6):265-79. PubMed ID: 1000103
    [No Abstract]   [Full Text] [Related]  

  • 4. [Administration of drugs in infusions].
    Honig C
    Ned Tijdschr Geneeskd; 1972 Jan; 116(5):189-94. PubMed ID: 5028757
    [No Abstract]   [Full Text] [Related]  

  • 5. Infusions.
    Heller WM
    Bull Parenter Drug Assoc; 1977; 31(5):259-64. PubMed ID: 922243
    [No Abstract]   [Full Text] [Related]  

  • 6. Particles in parenteral solutions.
    Kleinman LM; Tangrea JA; Gallelli JF
    Arch Pathol; 1973 Aug; 96(2):144. PubMed ID: 4718231
    [No Abstract]   [Full Text] [Related]  

  • 7. Excipient-drug interactions in parenteral formulations.
    Akers MJ
    J Pharm Sci; 2002 Nov; 91(11):2283-300. PubMed ID: 12379914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of instrumental colour measurement in development and quality control of drugs and pharmaceutical excipients.
    Subert J; Cizmárik J
    Pharmazie; 2008 May; 63(5):331-6. PubMed ID: 18557414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral formulations. I. Comparison of accelerated stability data with shelf-life studies.
    Lin SL
    Bull Parenter Drug Assoc; 1969; 23(6):269-88. PubMed ID: 5355889
    [No Abstract]   [Full Text] [Related]  

  • 10. A review of the effects of gamma radiation on pharmaceutical materials.
    Jacobs GP
    J Biomater Appl; 1995 Jul; 10(1):59-96. PubMed ID: 7473052
    [No Abstract]   [Full Text] [Related]  

  • 11. [Incompatibility and other problems in adding drugs to intravenous fluids].
    Hvidberg E; Bols T; Jacobsen N
    Ugeskr Laeger; 1973 Jun; 135(24):1221-9. PubMed ID: 4754570
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacopeia and preparations for cutaneous application].
    Esnault F; Etchegaray JP; Mallard C
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S40-5. PubMed ID: 17563714
    [No Abstract]   [Full Text] [Related]  

  • 13. [ICH4 and pharmacopoeias: similarities and differences].
    Artiges A
    Ann Pharm Fr; 1999 Mar; 57(2):161-7. PubMed ID: 10365473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The contamination of large volume parenteral solutions by foreign particles. Proposal for updating the Italian regulations].
    Pavanetto F; Montanari L; Conti B; Ponci R
    Farmaco Prat; 1986 Jan; 41(1):3-14. PubMed ID: 3956714
    [No Abstract]   [Full Text] [Related]  

  • 15. Particulate matter in parenteral products: a review.
    Borchert SJ; Abe A; Aldrich DS; Fox LE; Freeman JE; White RD
    J Parenter Sci Technol; 1986; 40(5):212-41. PubMed ID: 3540253
    [No Abstract]   [Full Text] [Related]  

  • 16. A cost-effective guide for the prevention of chemical phlebitis caused by the pH of the pharmaceutical agent.
    Harrigan CA
    NITA; 1984; 7(6):478-82. PubMed ID: 6568460
    [No Abstract]   [Full Text] [Related]  

  • 17. Ingredients in pharmaceutical preparations: a problem not value.
    Lubner GC
    Boll Chim Farm; 2002; 141(5):332. PubMed ID: 12481372
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of the quality of laboratory chemicals and reagents and diagnostic solutions].
    Voldán B; Sarsúnová M; Szücsová S
    Cesk Farm; 1969; 18(7):324-8. PubMed ID: 5349334
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies of the pH of drugs administered parenterally].
    Zietkiewicz W; Kostrzewska E
    Pol Tyg Lek; 1971 Jun; 26(25):937-9. PubMed ID: 5564508
    [No Abstract]   [Full Text] [Related]  

  • 20. [Difficulties encountered during formulation of a parenteral dosage form containing a poorly soluble drug].
    Kovács K; Orosz T; Stampf G; Antal I; Klebovich I; Ludányi K
    Acta Pharm Hung; 2009; 79(1):35-44. PubMed ID: 19526681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.